ActavisAnother breakout trade is shaping up in shares of large-cap drug maker Actavis (ACT). Actavis has been trading within a rectangle pattern for the last few months, bouncing between a horizontal resistance level above shares at $90 and a horizontal support level below shares down at $82.50. Yesterday's push through resistance is sending a buy signal for traders today.
5 Huge Stocks to Trade for Gains This Week
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts